The acute myeloid leukemia treatment market size was valued at USD 3.8 billion in 2023, driven by the increasing emphasis on providing personalized treatment for cancer patients. The market… Read More
(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Peripheral T-Cell Lymphoma pipeline constitutes 40+ key companies continuously working towards developi… Read More
DelveInsight’s “Recurrent/Metastatic Nasopharyngeal Carcinoma Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Recur… Read More
Delveinsight Business Research LLP
DelveInsight’s “Nasal Polyposis Market Insights, Epidemiology, and Market Forecast 2032” report delivers an in-depth understanding o… Read More
(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Peripheral T Cell Lymphomas pipeline constitutes 40+ key companies continuously working towards develop… Read More
The ‘Global Acute Myeloid Leukemia Treatment Market Share, Size, Report and Forecast 2023-2031’ by Expert Market Research gives an extensive outlook of the global acute myeloid l… Read More
Benzinga reports that stock analysts at the Royal Bank of Canada lowered their price target for Viracta Therapeutics (NASDAQ: VIRX) on Friday from $10.00 to $8.00. The previous price target… Read More
The Food and Drug Administration (FDA) has given clearance to an Investigational New Drug application to Viracta Therapeutics’ Phase Ib/II trial of all-combo treatment in advanced mali… Read More